~~<i id='77F3AB15B6'><strike id='77F3AB15B6'><tt id='77F3AB15B6'><pre id='77F3AB15B6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：knowledge 2025-08-11 09:46:06 - browse：23744

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Can gargling with Listerine treat gonorrhea of the mouth?

entertainment

hotspot

focus

entertainment

Inthe2011film"Limitless,"mysterypillsletBradleyCooper'sstrugglingwriteraccess100percentofhisbrain,ma

WSS

AMAs digital advisors table RPM coding reform proposal, again

Eli Lilly reports tirzepatide MASH success during Q4 earnings

AMAs digital advisors table RPM coding reform proposal, again

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Congress considering partial increase for doctor pay in Medicare

The effects of a landmark ruling on DNA ownership are becoming clearer

explore

fashion

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Brain MRIs reveal impact of 'toxic stress' on Black children

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Can gargling with Listerine treat gonorrhea of the mouth?

Affirmative action in medical school literally saved lives

BIO to announce reorganization, senior leaders expected to depart

Virginia high school admissions case could be legal follow

The creative science of coining drug names

Malaria cases in Florida and Texas: Here’s what you need to know

Resistance to opioid

hotspot

Abbott's new heart device gets FDA advisory panel nod

Study gives hint on South Asians’ higher risk of cardiovascular disease

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Has Bernie Sanders reached the limit of his pharma bullying effort?

STAT Boddities: What happens to the brain when we get scared?

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

focus

entertainment

entertainment

entertainment